Orexo AB (publ) (STO:ORX)
Sweden · Delayed Price · Currency is SEK 21.00
+1.18 (5.95%)
May 26, 2026, 5:29 PM CET
Orexo AB Market Cap
Orexo AB has a market cap or net worth of 733.35 million as of May 26, 2026. Its market cap has increased by 41.69% in one year.
Market Cap
733.35M
Enterprise Value
354.15M
Revenue
17.80M
Ranking
n/a
PE Ratio
1.41
Stock Price
21.00
Market Cap Chart
Since November 9, 2005, Orexo AB's market cap has decreased from 861.50M to 733.35M, a decrease of -14.87%. That is a compound annual growth rate of -0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 733.35M | -29.39% |
| Dec 30, 2025 | 1.04B | 72.00% |
| Dec 30, 2024 | 603.84M | 13.47% |
| Dec 29, 2023 | 532.14M | -17.90% |
| Dec 30, 2022 | 648.17M | -45.27% |
| Dec 30, 2021 | 1.18B | -30.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 13.30B |
| Cereno Scientific AB | 1.81B |
| EQL Pharma AB | 795.82M |
| Nanexa AB | 670.78M |
| Enzymatica AB | 577.71M |
| Cinclus Pharma Holding AB | 562.18M |
| Moberg Pharma AB | 490.69M |
| Dicot Pharma AB | 457.73M |